Artiva Biotherapeutics, Inc. Common Stock
$7.705
USD
Last updated on --.
24h volume198.68K
24h highest8.2350 USD
24h lowest7.4820 USD
24h Price movement-2.84%
ARTV recent prices
24 Hours
-2.84%-$0.225
30 days
-32.09%-$3.623
60 days
+17.36%+$1.170
90 days
+40.42%+$2.207
Key data
Previous close7.9300 USD
Market cap385.30M USD
Volume198.68K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.7900 USD
Net income (FY)-87.07M USD
Revenue (FY)--
Last report dateMay 8, 2026
About Artiva Biotherapeutics, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)106.00
Net income per employee (FY)-821.42K USD
Listed onNasdaq
ARTV conversion tables
 |  |
|---|---|
| 0.5 ARTV | 3.852 USD |
| 1 ARTV | 7.705 USD |
| 5 ARTV | 38.52 USD |
| 10 ARTV | 77.05 USD |
| |
|---|---|
| 0.5 USD | 0.064893 ARTV |
| 1 USD | 0.12979 ARTV |
| 5 USD | 0.64893 ARTV |
| 10 USD | 1.297 ARTV |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ARTV is trading at $7.705, -2.84% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ARTV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ARTV is currently trading at $7.705, -2.84% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ARTV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ARTV's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ARTV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ARTV's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Artiva Biotherapeutics, Inc. Common Stock's market cap is currently 385.30M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume198.68K
24h highest8.2350 USD
24h lowest7.4820 USD
24h Price movement-2.84%
Start trade with ARTV Perpetual
Sign up to trade